Authors:
BLANEY SM
NEEDLE MN
GILLESPIE A
SATO JK
REAMAN GH
BERG SL
ADAMSON PC
KRAILO MD
BLEYER WA
POPLACK DG
BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
Authors:
BLANEY SM
NEEDLE MN
GILLESPIE A
SATO JK
REAMAN GH
BERG SL
ADAMSON PC
KRAILO MD
BLEYER WA
POPLACK DG
BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
Authors:
BERG SL
BLANEY SM
ADAMSON PC
OBRIEN M
POPLACK DG
ARNDT C
BLATT J
BALIS FM
Citation: Sl. Berg et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS, Journal of clinical oncology, 16(1), 1998, pp. 181-186
Authors:
BLANEY SM
TAKIMOTO C
MURRY DJ
KUTTESCH N
MCCULLY C
COLE DE
GODWIN K
BALIS FM
Citation: Sm. Blaney et al., PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 9-AMINOCAMPTOTHECIN (9-AC), IRINOTECAN (CPT-11), AND SN-38 IN NONHUMAN-PRIMATES, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 464-468
Authors:
BLANEY SM
SEIBEL NL
OBRIEN M
REAMAN GH
BERG SL
ADAMSON PC
POPLACK DG
KRAILO MD
MOSHER R
BALIS FM
Citation: Sm. Blaney et al., PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1538-1543
Authors:
ADAMSON PC
REAMAN G
FINKLESTEIN JZ
FEUSNER J
BERG SL
BLANEY SM
OBRIEN M
MURPHY RF
BALIS FM
Citation: Pc. Adamson et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE IN COMBINATION WITH INTERFERON-ALPHA-2A IN PEDIATRIC-PATIENTS WITH REFRACTORY CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3330-3337
Citation: Sm. Blaney et Dg. Poplack, PHARMACOLOGICAL STRATEGIES FOR THE TREATMENT OF MENINGEAL MALIGNANCY, Investigational new drugs, 14(1), 1996, pp. 69-85
Authors:
BLANEY SM
PHILLIPS PC
PACKER RJ
HEIDEMAN RL
BERG SL
ADAMSON PC
ALLEN JC
SALLAN SE
JAKACKI RL
LANGE BJ
REAMAN GH
HOROWITZ ME
POPLACK DG
BALIS FM
Citation: Sm. Blaney et al., PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS, Cancer, 78(3), 1996, pp. 527-531
Authors:
BLANEY SM
POPLACK DG
GODWIN K
MCCULLY CL
MURPHY R
BALIS FM
Citation: Sm. Blaney et al., EFFECT OF BODY POSITION ON VENTRICULAR CSF METHOTREXATE CONCENTRATIONFOLLOWING INTRALUMBAR ADMINISTRATION, Journal of clinical oncology, 13(1), 1995, pp. 177-179
Authors:
BLANEY SM
COLE DE
GODWIN K
SUNG C
POPLACK DG
BALIS FM
Citation: Sm. Blaney et al., INTRATHECAL ADMINISTRATION OF TOPOTECAN IN NONHUMAN-PRIMATES, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 121-124
Authors:
BLANEY SM
DANIEL MJ
HARKER AJ
GODWIN K
BALIS FM
Citation: Sm. Blaney et al., PHARMACOKINETICS OF LAMIVUDINE AND BCH-189 IN PLASMA AND CEREBROSPINAL-FLUID OF NONHUMAN-PRIMATES, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2779-2782
Authors:
ADAMSON PC
BALLS FM
BELASCO JE
LANGE B
BERG SL
BLANEY SM
CRAIG C
POPLACK DG
Citation: Pc. Adamson et al., A PHASE-I TRIAL OF AMIFOSTINE (WR-2721) AND MELPHALAN IN CHILDREN WITH REFRACTORY CANCER, Cancer research, 55(18), 1995, pp. 4069-4072
Authors:
SUNG C
BLANEY SM
COLE DE
BALIS FM
DEDRICK RL
Citation: C. Sung et al., A PHARMACOKINETIC MODEL OF TOPOTECAN CLEARANCE FROM PLASMA AND CEREBROSPINAL-FLUID, Cancer research, 54(19), 1994, pp. 5118-5122
Authors:
BLANEY SM
GREM JL
BALIS FM
COLE DE
ADAMSON PC
POPLACK DG
Citation: Sm. Blaney et al., MECHANISM OF RESISTANCE TO CYCLOPENTENYL CYTOSINE (CPE-C) IN MOLT-4 LYMPHOBLASTS, Biochemical pharmacology, 45(7), 1993, pp. 1493-1501